MedPath

Mechanisms of Anabolic Resistance in Older Humans

Recruiting
Conditions
Aging
Registration Number
NCT06617195
Lead Sponsor
Mayo Clinic
Brief Summary

The purpose of this research is to understand how chronic inflammation affects muscle function and responses to exercise in older adults.

Detailed Description

Inflamed adipose tissue may contribute to blunted exercise response in skeletal muscle of older adults. The objective of this project is to evaluate a hypothesis that inflamed adipose secretes factors that activate inflammatory cascades in skeletal muscle, which may interfere with exercise-responsive molecular pathways and contribute to dysfunctional muscle phenotypes with aging. This project determine how adipose tissue influences skeletal muscle function and anabolic response to exercise in older adults. Young and older adults will complete studies to assess molecular response to acute exercise from protein synthesis rates, mRNA of exercise-responsive genes, and activation of signaling proteins in skeletal muscle. Adipose tissue will be assessed using a combination of non-invasive imaging and biopsy-based molecular phenotyping. The project will determine if acute exercise response is attenuated in older adults with inflamed adipose tissue phenotype.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
120
Inclusion Criteria

Not provided

Exclusion Criteria
  1. Diabetes or fasting plasma glucose 126 mg/dL
  2. Body mass index (BMI) 30 kg/m2
  3. Anemia (female subjects hemoglobin of <11 g/dl and male subjects hemoglobin <12 g/dl)
  4. Active coronary artery disease or history of unstable macrovascular disease (unstable angina, myocardial infarction, stroke, and revascularization of coronary, peripheral or carotid artery within 3 months of recruitment)
  5. Renal failure (serum creatinine > 1.5mg/dl)
  6. Chronic active liver disease (AST>144IU/L or ALT>165IU/L)
  7. Oral warfarin group medications or history of blood clotting disorders.
  8. Smoking
  9. Pregnancy or breastfeeding
  10. Alcohol consumption greater than 2 glasses/day or other substance abuse
  11. Untreated or uncontrolled hypothyroidism
  12. Debilitating chronic disease (at the discretion of the investigators)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Anabolic response2 months

Skeletal muscle protein synthesis rates will be measured from isotopic enrichment of muscle proteins

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Mayo Clinic

🇺🇸

Rochester, Minnesota, United States

Mayo Clinic
🇺🇸Rochester, Minnesota, United States
Ian R Lanza, PhD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.